Ohcanbohtosat - Al‐Dallal, Salma

Acromegaly: a challenging condition to diagnose Dahkki AlDallal, Salma

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Ofatumumab – a valid treatment option for chronic lymphocytic leukemia patients Dahkki AlDallal, Salma M

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Mini review: leg ulcers - a secondary complication of sickle cell disease Dahkki AlDallal, Salma M

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Voxelotor: A Ray of Hope for Sickle Disease Dahkki AlDallal, Salma M

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Yescarta: A New Era for Non-Hodgkin Lymphoma Patients Dahkki AlDallal, Salma M

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Prevalence of Anemia in Type 2 Diabetic Patients Dahkki AlDallal, Salma M., Jena, Nirupama

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Zfp521 promotes B-cell viability and cyclin D1 gene expression in a B cell culture system Dahkki Al Dallal, Salma, Wolton, Kathryn, Hentges, Kathryn E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Successful Nilotinib Treatment in a Child with Chronic Myeloid Leukemia Dahkki Al-Jafar, Hassan A., Al-Mulla, Ali, AlDallal, Salma, Buhamad, Jaber H., Askar, Haifa

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria Dahkki Al-Jafar, Hassan A., AlDallal, Salma M., Askar, Haifa A., Aljeraiwi, Ali M., Al-Alansari, Ahmad

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Transcriptional regulation of the proto‐oncogene Zfp521 by SPI1 (PU.1) and HOXC13 Dahkki Yu, Ming, Al‐Dallal, Salma, Al‐Haj, Latifa, Panjwani, Shiraj, McCartney, Akina S., Edwards, Sarah M., Manjunath, Pooja, Walker, Catherine, Awgulewitsch, Alexander, Hentges, Kathryn E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta